id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-2273-0011,FDA,FDA-2019-E-2273,Notice of Final Determination and Requirement for Election Letter,Other,Letter(s),2024-03-06T05:00:00Z,2024,3,2024-03-06T05:00:00Z,,2024-03-06T18:47:25Z,,0,0,09000064863f485e
FDA-2019-E-2273-0010,FDA,FDA-2019-E-2273,"Letter from U.S. Patent and Trademark Office to Millen White Zelano and Branigan, P.C.",Other,Letter(s),2024-02-28T05:00:00Z,2024,2,2024-02-28T05:00:00Z,,2024-02-28T21:10:38Z,,0,0,090000648641eadf
FDA-2019-E-2273-0009,FDA,FDA-2019-E-2273,"Withdrawal of Application from U.S. Patent and Trademark Office to Millen White Zelano and Branigan, P.C.",Other,Letter(s),2024-02-28T05:00:00Z,2024,2,2024-02-28T05:00:00Z,,2024-02-28T21:10:23Z,,0,0,090000648641eaca
FDA-2019-E-2273-0008,FDA,FDA-2019-E-2273,Letter from U. S. Patent and Trademark Office,Other,Letter(s),2024-02-22T05:00:00Z,2024,2,2024-02-22T05:00:00Z,,2024-02-22T19:44:29Z,,0,0,09000064863f48b2
FDA-2019-E-2273-0007,FDA,FDA-2019-E-2273,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2023-07-13T04:00:00Z,2023,7,2023-07-13T04:00:00Z,,2023-07-13T17:57:22Z,,0,0,0900006485ca0e48
FDA-2019-E-2273-0006,FDA,FDA-2019-E-2273,"Determination of Regulatory Review Period for Purposes of Patent Extension; PREVYMIS, New Drug Application 209939",Notice,Determinations,2022-11-14T05:00:00Z,2022,11,2022-11-14T05:00:00Z,2023-01-14T04:59:59Z,2022-11-14T15:02:40Z,2022-24718,0,0,09000064854aa583
FDA-2019-E-2273-0005,FDA,FDA-2019-E-2273,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T16:02:44Z,,0,0,09000064852cdc6f
FDA-2019-E-2273-0004,FDA,FDA-2019-E-2273,Letter from Office of Patent Legal Administration/  Office of the Deputy Commissioner for Patents to FDA CDER,Other,Letter(s),2022-05-27T04:00:00Z,2022,5,2022-05-27T04:00:00Z,,2022-05-27T18:12:00Z,,0,0,0900006485100597
FDA-2019-E-2273-0003,FDA,FDA-2019-E-2273,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2019-06-21T04:00:00Z,2019,6,2019-06-21T04:00:00Z,,2019-06-21T15:49:15Z,,0,0,0900006483d31769
FDA-2019-E-2273-0001,FDA,FDA-2019-E-2273,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,,2019-05-09T16:58:14Z,,0,0,0900006483c4e650
FDA-2019-E-2273-0002,FDA,FDA-2019-E-2273,Patent Extension Application from Millen White Zelano & Branigan PC (on behalf of AiCuris Anti-Infective Cures GmbH),Other,Application,2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,,2019-05-09T17:03:49Z,,0,0,0900006483c4e3d8